Kaplan-Meier curves indicated that NSCLC patients with low SIRT2 levels had a significantly shorter overall survival (Figure 1F), suggesting that low SIRT2 levels in NSCLC may be associated with poor patient survival. This evidence concerns the gene SIRT2 and non-small cell lung carcinoma.